These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15164434)

  • 1. Management of in-transit metastases from cutaneous malignant melanoma.
    Hayes AJ; Clark MA; Harries M; Thomas JM
    Br J Surg; 2004 Jun; 91(6):673-82. PubMed ID: 15164434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of in-transit melanoma metastases.
    Testori A; Ribero S; Bataille V
    Eur J Surg Oncol; 2017 Mar; 43(3):544-560. PubMed ID: 27923593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastases.
    Kandamany N; Mahaffey P
    Lasers Med Sci; 2009 May; 24(3):411-4. PubMed ID: 18566850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.
    Deroose JP; Grünhagen DJ; van Geel AN; de Wilt JH; Eggermont AM; Verhoef C
    Br J Surg; 2011 Nov; 98(11):1573-80. PubMed ID: 21739427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of surgery on the course of melanoma.
    Lejeune FJ
    Recent Results Cancer Res; 2002; 160():151-7. PubMed ID: 12079209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of in-transit melanoma of the extremity with isolated limb perfusion.
    Fraker DL
    Curr Treat Options Oncol; 2004 Jun; 5(3):173-84. PubMed ID: 15115646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma.
    Roses DF; Harris MN; Rigel D; Carrey Z; Friedman R; Kopf AW
    Ann Surg; 1983 Jul; 198(1):65-9. PubMed ID: 6859994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
    Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
    Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cutaneous metastases from malignant melanoma using the carbon-dioxide laser.
    Hill S; Thomas JM
    Eur J Surg Oncol; 1993 Apr; 19(2):173-7. PubMed ID: 8491321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma.
    Olofsson R; Mattsson J; Lindnér P
    Int J Hyperthermia; 2013 Sep; 29(6):551-7. PubMed ID: 23865737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for in-transit metastasis in patients with cutaneous melanoma].
    Clemente-Ruiz de Almiron A; Serrano-Ortega S
    Actas Dermosifiliogr; 2012 Apr; 103(3):207-13. PubMed ID: 21899829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for unresectable recurrent and in-transit extremity melanoma.
    Gimbel MI; Delman KA; Zager JS
    Cancer Control; 2008 Jul; 15(3):225-32. PubMed ID: 18596674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical issues in the management of melanoma.
    Fraker DL
    Curr Opin Oncol; 1997 Mar; 9(2):183-8. PubMed ID: 9161799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-transit melanoma: an individualized approach.
    Grotz TE; Mansfield AS; Kottschade LA; Erickson LA; Otley CC; Markovic SN; Jakub JW
    Oncology (Williston Park); 2011 Dec; 25(14):1340-8. PubMed ID: 22329185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional non-nodal metastases of cutaneous melanoma.
    Cascinelli N; Bufalino R; Marolda R; Belli F; Nava M; Galluzzo D; Santinami M; Levene A
    Eur J Surg Oncol; 1986 Jun; 12(2):175-80. PubMed ID: 3709823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon dioxide laser ablation for the management of in-transit cutaneous malignant melanoma metastases.
    Kandamany N; Mahaffey P
    J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1111-3. PubMed ID: 18458014
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there increased risk of local and in-transit recurrence following sentinel lymph node biopsy?
    Cerovac S; Mashhadi SA; Williams AM; Allan RA; Stanley PR; Powell BW
    J Plast Reconstr Aesthet Surg; 2006; 59(5):487-93. PubMed ID: 16631558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Contemporary Role of Major Amputation in the Management of Advanced Limb Melanoma.
    Read RL; Stalley P; Thompson JF
    Ann Surg Oncol; 2015 Nov; 22(12):4067-72. PubMed ID: 25712799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are locoregional cutaneous metastases in melanoma predictable?
    Borgstein PJ; Meijer S; van Diest PJ
    Ann Surg Oncol; 1999; 6(3):315-21. PubMed ID: 10340893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.